Quick Answer
NovaBridge Biosciences reported Common Stock Shares Outstanding of 187.45 million shares for the year ending 2024.
- NovaBridge Biosciences showed an increase of +1.0% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 3, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), NovaBridge Biosciences's Common Stock Shares Outstanding has grown by 2,141.3%.
- Historical annual values: Fiscal year 2024: 187.45 million shares | Fiscal year 2023: 185.61 million shares | Fiscal year 2022: 190.88 million shares | Fiscal year 2021: 183.83 million shares | Fiscal year 2020: 164.89 million shares | Fiscal year 2019: 8.36 million shares | Fiscal year 2018: 8.36 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: